4//SEC Filing
Ocumension Therapeutics 4
Accession 0001840315-24-000002
CIK 0001314102other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 6:55 PM ET
Size
5.2 KB
Accession
0001840315-24-000002
Insider Transaction Report
Form 4
Ocumension Therapeutics
10% Owner
Transactions
- Sale
common stock
2024-01-11$19.45/sh−1,910,500$37,159,225→ 100,221 total
Footnotes (1)
- [F1]T+2 settlement on Jan 16
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001840315
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 6:55 PM ET
- Size
- 5.2 KB